[HTML][HTML] Use of monoclonal antibody to treat COVID-19 in children and adolescents: risk of abuse of prescription and exacerbation of health inequalities
S Esposito, S Zona, A Pession, L Iughetti, GB Migliori… - Pharmaceuticals, 2021 - mdpi.com
Monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 in infected patients are a new
class of antiviral agents approved as a type of passive immunotherapy. They should be …
class of antiviral agents approved as a type of passive immunotherapy. They should be …
[HTML][HTML] Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities
S Esposito, S Zona, A Pession, L Iughetti… - …, 2021 - ncbi.nlm.nih.gov
Monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 in infected patients are a new
class of antiviral agents approved as a type of passive immunotherapy. They should be …
class of antiviral agents approved as a type of passive immunotherapy. They should be …
Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities
S Esposito, S Zona, A Pession, L Iughetti… - …, 2021 - search.proquest.com
Monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 in infected patients are a new
class of antiviral agents approved as a type of passive immunotherapy. They should be …
class of antiviral agents approved as a type of passive immunotherapy. They should be …
Use of monoclonal antibody to treat covid-19 in children and adolescents: Risk of abuse of prescription and exacerbation of health inequalities
S Esposito, S Zona, A Pession, L Iughetti… - …, 2021 - air.unipr.it
Monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 in infected patients are a new
class of antiviral agents approved as a type of passive immunotherapy. They should be …
class of antiviral agents approved as a type of passive immunotherapy. They should be …
Use of monoclonal antibody to treat COVID-19 in children and adolescents: risk of abuse of prescription and exacerbation of health inequalities.
S Esposito, S Zona, A Pession, L Iughetti, GB Migliori… - 2021 - cabidigitallibrary.org
Monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 in infected patients are a new
class of antiviral agents approved as a type of passive immunotherapy. They should be …
class of antiviral agents approved as a type of passive immunotherapy. They should be …
Use of monoclonal antibody to treat covid-19 in children and adolescents: Risk of abuse of prescription and exacerbation of health inequalities
S Esposito, S Zona, A Pession, L Iughetti… - …, 2021 - iris.unimore.it
Monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 in infected patients are a new
class of antiviral agents approved as a type of passive immunotherapy. They should be …
class of antiviral agents approved as a type of passive immunotherapy. They should be …
Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities.
S Esposito, S Zona, A Pession, L Iughetti… - Pharmaceuticals …, 2021 - europepmc.org
Monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 in infected patients are a new
class of antiviral agents approved as a type of passive immunotherapy. They should be …
class of antiviral agents approved as a type of passive immunotherapy. They should be …
Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities
S Esposito, S Zona, A Pession… - Pharmaceuticals …, 2021 - pubmed.ncbi.nlm.nih.gov
Monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 in infected patients are a new
class of antiviral agents approved as a type of passive immunotherapy. They should be …
class of antiviral agents approved as a type of passive immunotherapy. They should be …
Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities.
S Esposito, S Zona, A Pession… - Pharmaceuticals …, 2021 - search.ebscohost.com
Monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 in infected patients are a new
class of antiviral agents approved as a type of passive immunotherapy. They should be …
class of antiviral agents approved as a type of passive immunotherapy. They should be …
[PDF][PDF] Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities
S Esposito, S Zona, A Pession, L Iughetti… - …, 2021 - pdfs.semanticscholar.org
Monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 in infected patients are a new
class of antiviral agents approved as a type of passive immunotherapy. They should be …
class of antiviral agents approved as a type of passive immunotherapy. They should be …